NBIX vs WSBCO
Neurocrine Biosciences Inc (NBIX) versus WesBanco, Inc. (WSBCO) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
WesBanco, Inc. (WSBCO) is a banks - regional company listed on NASDAQ.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
WSBCO does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. WSBCO currently screens at market cap $0.
Not investment advice. Open the NBIX and WSBCO stock pages for the full models.
Not investment advice.